Clinical trial
Fat Distribution in Healthy Early Postmenopausal Women
NCT00335218 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00335218 |
|---|---|
| Title | Fat Distribution in Healthy Early Postmenopausal Women |
| Official title | A Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled, Two-arm, Phase IV Study to Investigate the Influence of a Continuous Combined Estrogen-progestin Regimen Containing 2 mg Estradiol Valerate and 2 mg Dienogest (Climodien® / Lafamme®) on the Fat Distribution in Otherwise… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy, Postmenopause |
| Intervention type | Drug |
| Interventions | Climodien / Lafamme (BAY86-5027), Placebo |
| Enrollment | 67 |
| Start date | Jul 1, 2002 |
| Completion | Aug 1, 2004 |
| First posted | Jun 9, 2006 |
| Last update posted | Dec 30, 2014 |
| Countries | Austria |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: